Study analysis · bioRxiv · 2025
A 67% cut to one amino acid extended male mice's median lifespan by 23.42% relative—but female mice got no median lifespan boost.
In a lifelong mouse study, restricting valine improved health in both sexes but only extended median lifespan in males, by 23.42% relative; absolute extra days were not reported.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study is like a fair test in mice where some got a special diet and others didn't, and the researchers watched what happened over their whole lives. Because the mice were randomly assigned, we can be pretty sure the diet caused the changes seen in mice. But mice are not people, so we can't say the same diet would do the same thing in humans without testing it in humans.
What’s the bottom line?
Scientists fed mice a diet with 67% less valine, one of the branched-chain amino acids, for their whole lives. They compared these mice with mice eating a normal control diet.
How strong is this study?
The study was well done because it used a control group, random assignment, and followed the mice for their entire lives, looking at many aspects of health. However, the researchers didn't say if they knew which mice got which diet when measuring outcomes, and they only used one type of mouse and one dose. That means the results are strong for these mice but might not apply to other mice or to people.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
56 / 100
- Randomization+20/20
- Blindingblinding unclear
- Control group+15/15
- Sample sizeno sample size reported
- Follow-up+10/10
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 516 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. Randomization and controlled diet allow causal inference within the C57BL/6J mouse model. However, this is an animal study, so causation in humans cannot be established. Additional limitations include unknown blinding, single inbred strain, single level of valine restriction, intervention started at 4 weeks of age, and sex-specific effects. These factors restrict generalizability and preclude direct human causal claims.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding statement was provided in the text; unable to assess potential conflicts or funder involvement.
The provided text lacks a COI/competing interests section and a funding statement. The study used commercial diets from Inotiv, but no industry funding or author industry employment is disclosed. Author affiliations include the William S. Middleton Memorial Veterans Hospital and the University of Wisconsin-Madison, but no industry ties are stated.
Key takeaways
- 01
Male mice on low-valine food had a 23.42% relative increase in median lifespan, but female mice did not have a median lifespan increase.
- 02
Maximum lifespan rose 14.15% relative in males and 7.07% relative in females.
- 03
Both sexes had better metabolic health, less frailty, and lower cancer prevalence at necropsy (male p=0.0559, female p=0.0275).
- 04
Absolute lifespan values were not reported in the study.
- 05
The study reports relative lifespan changes: about a 23% relative longer median life for male mice and a 14% relative longer maximum life for males, but the absolute lifespan values were not reported, so we cannot say how many extra months or days that means.
- 06
Cancer prevalence was lower with valine restriction, but absolute cancer risk numbers were not reported, so we cannot calculate how many fewer cancer cases per 1,000 mice.
- 07
This is mouse data, not human data.
Surprising findings
- Male mice got a 23.42% relative median lifespan extension, but females got no median lifespan extension despite healthspan improvements.Many longevity interventions either help both sexes or show female-specific benefits; here the lifespan benefit was male-specific while health benefits were shared.
- Hepatic mTORC1 signaling increased with valine restriction, even though valine is an mTORC1 agonist.The prevailing model says restricting BCAAs should reduce mTORC1, which is often linked to longevity.
- Increased energy expenditure was not mediated by the FGF21-UCP1 axis.Protein restriction benefits are commonly attributed to FGF21 and UCP1-driven thermogenesis; this study found no FGF21 increase.
- Female mice improved short-term memory, but male mice did not—even though males had greater reductions in neuroinflammatory markers.It uncouples neuroinflammation reduction from cognitive improvement in a sex-specific way.
- Absolute lifespan values were not reported, only relative percentages.Without absolute numbers, we cannot say how many extra days or months the mice lived, making the practical size of the effect unclear.
Practical takeaways
Do not cut valine from your diet based on this study. There are no human trials, and valine is an essential amino acid.
This is a mouse preprint using one inbred strain, one restriction level, and starting at 4 weeks of age. Absolute human-relevant effects are unknown.
low confidenceIf you're interested in protein quality and aging, focus on overall diet quality rather than singling out valine.
The study does not tell us whether lowering valine in humans is safe or effective; essential amino acids are required for health.
low confidenceFor researchers: replicate this in genetically heterogeneous mice, start in adulthood, and test multiple valine restriction levels.
The current study used only C57BL/6J mice and one 67% restriction level, so dose and strain effects are unknown.
medium confidenceWhen reading longevity headlines, check whether the effect is relative or absolute and whether both sexes were analyzed separately.
This study reports relative lifespan changes and does not report absolute lifespan values.
high confidenceWhy this study matters
Sex-specific lifespan: males win, females don't
Lifelong 67% valine restriction increased median lifespan by 23.42% relative in male C57BL/6J mice versus isocaloric controls, but there was no median lifespan extension in females. Maximum lifespan rose 14.15% relative in males and 7.07% relative in females. Absolute lifespan values were not reported, so we don't know how many extra days or months this means.
It challenges the idea that anti-aging diets work the same for everyone and highlights sex as a major variable in longevity research.
Healthspan improved in both sexes, even without female lifespan gain
Both male and female mice on valine restriction showed better metabolic health, less frailty, and lower cancer prevalence at necropsy (p=0.0559 in males, p=0.0275 in females). They were leaner, had better glucose tolerance, and less hepatic steatosis without eating fewer calories. Absolute cancer risk was not reported.
It suggests healthspan and lifespan can be uncoupled—females lived healthier but not longer on average.
The mTORC1 paradox: less valine, more mTORC1 in liver
Valine is a branched-chain amino acid thought to activate mTORC1, but valine restriction increased hepatic mTORC1 signaling in both sexes, measured by increased phosphorylation of S6K1 T389. At the same time, it reduced hepatic senescence measured by SA-β-Gal staining.
It flips a central assumption in aging biology—that less mTORC1 is always better—and suggests context matters.
Energy burn without the usual FGF21-UCP1 pathway
Valine-restricted mice burned more energy, but FGF21 did not increase and UCP1 was not elevated. Instead, the study found increased Elovl3 expression and signs of brown adipose tissue thermogenesis via a different mechanism.
Most protein-restriction benefits are blamed on FGF21; this study says valine restriction may work through a separate route.
Brain benefits: less neuroinflammation, but memory boost only in females
Valine restriction reduced markers of neuroinflammation (IBA1 microglia and GFAP astrocytes) in multiple brain regions, with a larger effect in males. Yet only female mice showed improved short-term memory on a novel object recognition test (diet-sex interaction p=0.0543).
It shows brain aging and cognition can respond differently by sex, and inflammation reduction alone may not equal memory improvement.
Big caveats: preprint, one mouse strain, one dose, no absolute numbers
This is a preprint not yet peer-reviewed. It used a single inbred strain (C57BL/6J), a single 67% valine restriction level, and started at 4 weeks of age. Absolute lifespan and absolute cancer-risk values were not reported, and the study's own quality score was low (16/100).
It's a reminder that exciting mouse longevity findings often have major translation gaps before they mean anything for humans.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists fed mice a diet with 67% less valine, one of the branched-chain amino acids, for their whole lives. They compared these mice with mice eating a normal control diet.
Research results
Male mice on low-valine food had a 23.42% relative increase in median lifespan, but female mice did not have a median lifespan increase. Maximum lifespan rose 14.15% relative in males and 7.07% relative in females. Both sexes had better metabolic health, less frailty, and lower cancer prevalence at necropsy (male p=0.0559, female p=0.0275). Absolute lifespan values were not reported in the study.
What this means - more context
The study reports relative lifespan changes: about a 23% relative longer median life for male mice and a 14% relative longer maximum life for males, but the absolute lifespan values were not reported, so we cannot say how many extra months or days that means. Cancer prevalence was lower with valine restriction, but absolute cancer risk numbers were not reported, so we cannot calculate how many fewer cancer cases per 1,000 mice. This is mouse data, not human data.
Test whether lifelong 67% dietary valine restriction improves healthspan and lifespan in male and female C57BL/6J mice.
In a lifelong randomized controlled mouse study, 67% valine restriction improved metabolic health, reduced frailty and cancer prevalence in both sexes, reduced neuroinflammation, and extended median lifespan by 23.42% relative in males but not females. Maximum lifespan increased 14.15% relative in males and 7.07% relative in females. Absolute lifespan values were not reported in the abstract.
Methods Used
Male and female C57BL/6J mice were randomized at 4 weeks of age to an isocaloric amino-acid-defined control diet or a diet with 67% valine restriction, continued lifelong. Outcomes included lifespan, body composition, glucose/insulin tolerance, energy expenditure, frailty index, necropsy cancer prevalence, cognition, neuroinflammation, transcriptomics, and immunoblotting across tissues.
Main Finding
Valine restriction extended median lifespan by 23.42% relative in male C57BL/6J mice versus isocaloric control, with no median lifespan extension in females; maximum lifespan increased 14.15% relative in males and 7.07% relative in females. Absolute lifespan values were not reported. Both sexes showed improved metabolic health, reduced frailty, and lower cancer prevalence at necropsy (p=0.0559 males, p=0.0275 females).
Confidence Level
Moderate. This is a randomized controlled animal experiment with lifelong follow-up and multi-tissue outcomes, but it is a preprint not peer-reviewed, used a single inbred mouse strain and a single 67% valine restriction level started at 4 weeks, and did not report absolute lifespan or absolute cancer-risk values. Not retracted; no corrections reported.
Study Flags
Red Flags
- •Preprint not peer-reviewed
- •Single inbred C57BL/6J strain and single 67% valine restriction level started at 4 weeks of age
- •Absolute lifespan and absolute cancer-risk values not reported; female median lifespan was not extended despite healthspan benefits
Surprising Findings
Male mice got a 23.42% relative median lifespan extension, but females got no median lifespan extension despite healthspan improvements.
Many longevity interventions either help both sexes or show female-specific benefits; here the lifespan benefit was male-specific while health benefits were shared.
Practical Takeaways
Do not cut valine from your diet based on this study. There are no human trials, and valine is an essential amino acid.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 516 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Animal RCT
Subject
Lower probability
on the GRADE evidence scale
This study is like a fair test in mice where some got a special diet and others didn't, and the researchers watched what happened over their whole lives. Because the mice were randomly assigned, we can be pretty sure the diet caused the changes seen in mice. But mice are not people, so we can't say the same diet would do the same thing in humans without testing it in humans.
Strengths
- Randomized controlled design with control and valine-restricted groups.
- Lifelong intervention with longitudinal follow-up.
- Both male and female mice included, allowing sex-specific analyses.
Weaknesses
- Blinding status unknown; potential performance and detection bias.
- Single inbred strain and single level of restriction.
- Intervention started at 4 weeks of age, limiting translatability to adult interventions.
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists fed mice a diet with 67% less valine, one of the branched-chain amino acids, for their whole lives. They compared these mice with mice eating a normal control diet.
Research results
Male mice on low-valine food had a 23.42% relative increase in median lifespan, but female mice did not have a median lifespan increase. Maximum lifespan rose 14.15% relative in males and 7.07% relative in females. Both sexes had better metabolic health, less frailty, and lower cancer prevalence at necropsy (male p=0.0559, female p=0.0275). Absolute lifespan values were not reported in the study.
What this means - more context
The study reports relative lifespan changes: about a 23% relative longer median life for male mice and a 14% relative longer maximum life for males, but the absolute lifespan values were not reported, so we cannot say how many extra months or days that means. Cancer prevalence was lower with valine restriction, but absolute cancer risk numbers were not reported, so we cannot calculate how many fewer cancer cases per 1,000 mice. This is mouse data, not human data.
Test whether lifelong 67% dietary valine restriction improves healthspan and lifespan in male and female C57BL/6J mice.
In a lifelong randomized controlled mouse study, 67% valine restriction improved metabolic health, reduced frailty and cancer prevalence in both sexes, reduced neuroinflammation, and extended median lifespan by 23.42% relative in males but not females. Maximum lifespan increased 14.15% relative in males and 7.07% relative in females. Absolute lifespan values were not reported in the abstract.
Methods Used
Male and female C57BL/6J mice were randomized at 4 weeks of age to an isocaloric amino-acid-defined control diet or a diet with 67% valine restriction, continued lifelong. Outcomes included lifespan, body composition, glucose/insulin tolerance, energy expenditure, frailty index, necropsy cancer prevalence, cognition, neuroinflammation, transcriptomics, and immunoblotting across tissues.
Main Finding
Valine restriction extended median lifespan by 23.42% relative in male C57BL/6J mice versus isocaloric control, with no median lifespan extension in females; maximum lifespan increased 14.15% relative in males and 7.07% relative in females. Absolute lifespan values were not reported. Both sexes showed improved metabolic health, reduced frailty, and lower cancer prevalence at necropsy (p=0.0559 males, p=0.0275 females).
Confidence Level
Moderate. This is a randomized controlled animal experiment with lifelong follow-up and multi-tissue outcomes, but it is a preprint not peer-reviewed, used a single inbred mouse strain and a single 67% valine restriction level started at 4 weeks, and did not report absolute lifespan or absolute cancer-risk values. Not retracted; no corrections reported.
Study Flags
Red Flags
- •Preprint not peer-reviewed
- •Single inbred C57BL/6J strain and single 67% valine restriction level started at 4 weeks of age
- •Absolute lifespan and absolute cancer-risk values not reported; female median lifespan was not extended despite healthspan benefits
Surprising Findings
Male mice got a 23.42% relative median lifespan extension, but females got no median lifespan extension despite healthspan improvements.
Many longevity interventions either help both sexes or show female-specific benefits; here the lifespan benefit was male-specific while health benefits were shared.
Practical Takeaways
Do not cut valine from your diet based on this study. There are no human trials, and valine is an essential amino acid.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 516 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Animal RCT
Subject
Lower probability
on the GRADE evidence scale
This study is like a fair test in mice where some got a special diet and others didn't, and the researchers watched what happened over their whole lives. Because the mice were randomly assigned, we can be pretty sure the diet caused the changes seen in mice. But mice are not people, so we can't say the same diet would do the same thing in humans without testing it in humans.
Strengths
- Randomized controlled design with control and valine-restricted groups.
- Lifelong intervention with longitudinal follow-up.
- Both male and female mice included, allowing sex-specific analyses.
Weaknesses
- Blinding status unknown; potential performance and detection bias.
- Single inbred strain and single level of restriction.
- Intervention started at 4 weeks of age, limiting translatability to adult interventions.
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The study was well done because it used a control group, random assignment, and followed the mice for their entire lives, looking at many aspects of health. However, the researchers didn't say if they knew which mice got which diet when measuring outcomes, and they only used one type of mouse and one dose. That means the results are strong for these mice but might not apply to other mice or to people.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
56 / 100
- Randomization+20/20
- Blindingblinding unclear
- Control group+15/15
- Sample sizeno sample size reported
- Follow-up+10/10
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 516 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. Randomization and controlled diet allow causal inference within the C57BL/6J mouse model. However, this is an animal study, so causation in humans cannot be established. Additional limitations include unknown blinding, single inbred strain, single level of valine restriction, intervention started at 4 weeks of age, and sex-specific effects. These factors restrict generalizability and preclude direct human causal claims.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding statement was provided in the text; unable to assess potential conflicts or funder involvement.
The provided text lacks a COI/competing interests section and a funding statement. The study used commercial diets from Inotiv, but no industry funding or author industry employment is disclosed. Author affiliations include the William S. Middleton Memorial Veterans Hospital and the University of Wisconsin-Madison, but no industry ties are stated.